• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS Pathog . Evidence for vagal sensory neural involvement in influenza pathogenesis and disease

tetano

Editor, Senior Moderator
PLoS Pathog


. 2024 Apr 16;20(4):e1011635.
doi: 10.1371/journal.ppat.1011635. Online ahead of print. Evidence for vagal sensory neural involvement in influenza pathogenesis and disease

Nathalie A J Verzele[SUP] 1 2 [/SUP], Brendon Y Chua[SUP] 3 [/SUP], Kirsty R Short[SUP] 1 4 [/SUP], Aung Aung Kywe Moe[SUP] 5 [/SUP], Isaac N Edwards[SUP] 1 [/SUP], Helle Bielefeldt-Ohmann[SUP] 1 4 [/SUP], Katina D Hulme[SUP] 1 [/SUP], Ellesandra C Noye[SUP] 1 [/SUP], Marcus Z W Tong[SUP] 1 [/SUP], Patrick C Reading[SUP] 3 6 [/SUP], Matthew W Trewella[SUP] 2 [/SUP], Stuart B Mazzone[SUP] 2 [/SUP], Alice E McGovern[SUP] 2 [/SUP]



Affiliations
Abstract

Influenza A virus (IAV) is a common respiratory pathogen and a global cause of significant and often severe morbidity. Although inflammatory immune responses to IAV infections are well described, little is known about how neuroimmune processes contribute to IAV pathogenesis. In the present study, we employed surgical, genetic, and pharmacological approaches to manipulate pulmonary vagal sensory neuron innervation and activity in the lungs to explore potential crosstalk between pulmonary sensory neurons and immune processes. Intranasal inoculation of mice with H1N1 strains of IAV resulted in stereotypical antiviral lung inflammation and tissue pathology, changes in breathing, loss of body weight and other clinical signs of severe IAV disease. Unilateral cervical vagotomy and genetic ablation of pulmonary vagal sensory neurons had a moderate effect on the pulmonary inflammation induced by IAV infection, but significantly worsened clinical disease presentation. Inhibition of pulmonary vagal sensory neuron activity via inhalation of the charged sodium channel blocker, QX-314, resulted in a moderate decrease in lung pathology, but again this was accompanied by a paradoxical worsening of clinical signs. Notably, vagal sensory ganglia neuroinflammation was induced by IAV infection and this was significantly potentiated by QX-314 administration. This vagal ganglia hyperinflammation was characterized by alterations in IAV-induced host defense gene expression, increased neuropeptide gene and protein expression, and an increase in the number of inflammatory cells present within the ganglia. These data suggest that pulmonary vagal sensory neurons play a role in the regulation of the inflammatory process during IAV infection and suggest that vagal neuroinflammation may be an important contributor to IAV pathogenesis and clinical presentation. Targeting these pathways could offer therapeutic opportunities to treat IAV-induced morbidity and mortality.


 
Back
Top Bottom